Influenza – current clinical practice

Czech version

Authors: Husa Petr
Authors‘ workplace: Klinika infekčních chorob Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
Published in: Geriatrie a Gerontologie 2024, 13, č. 2: 86-91
Category: Review Article

Overview

During the covid pandemic, influenza took a back seat. Its prevalence dropped dramatically due to the introduction of anti-epidemic measures. Following their relaxation, influenza has returned unchanged and continues to be a major health problem, affecting mostly people over 65 years of age. The positive aspect of the pandemic caused by a similar respiratory virus is the widening of the range and availability of diagnostic tests. Early diagnosis is essential in the treatment of influenza because the only available antiviral drug, oseltamivir, is only effective if given within 2 days of the onset of symptoms. The inadequate spectrum of antivirals further emphasizes the importance of regular vaccination in persons at risk not only against influenza but also against pneumococcal and haemophilus diseases, which are the most common causative agents of bacterial superinfections superimposed on influenza-induced lower respiratory tract involvement. It is bacterial superinfection that is the most important cause of mortality in influenza.

Keywords:

flu, influenza, oseltamivir, bacterial superinfection, viral pneumonia

Sources

1. Dattani S, Spooner F, Roser M. How many people die from the flu? [online] Our World Data. [cit.2024-04-24]. Dostupné z https://
ourworldindata.org/influenza-deaths.

2. Beneš J. Infekční lékařství. 1. vydání. Praha: Galén 2009.

3. Centers for Disease Control and Prevention. How flu viruses can change. [online] [cit.2024-04-24]. Dostupné z https://www.cdc.gov/flu/about/viruses/change.htm.

4. World Health Organization. Coronavirus disease (COVID-19) pandemic. [online] [cit.2024-04-22]. Dostupné z https://www.who.int/europe/emergencies/situations/covid-19.

5. Pendrey CG, Strachan J, Peck H, et al. The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022. Eurosurveillance. 2023; 28(37): 2300118.

6. Dhanasekaran V, Sullivan S,
Edwards K, et al. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun 2022; 13(1): 1721.

7. NRL pro chřipku a nechřipková respirační onemocnění. Data, respirační viry. SZÚ [online]. Oficiální web Státního zdravotního ústavu v Praze. [cit.2024-04-22]. Dostupné z: https://szu.cz/publikace-szu/data/akutni-respiracni-infekce-chripka/.

8. European Centers for Diasease control and Prevention. Seasonal influenza – Annual Epidemiological Report for 2022/2023. [online] [cit.2024-04-22]. Dostupné z: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-annual-epidemiological-report-20222023.

9. Hartshorn KL. New look at an old problem: bacterial superinfection after influenza. Am J Pathol 2010; 176(2): 536–539.

10. Weerakkody Y. H1N1 influenza | Radiology Reference Article | [online] Radiopaedia.org. Radio-
paedia. [cit. 2024-04-27]. Dostupné z: https://radiopaedia.org/articles/h1n1-influenza?lang=us.

11. Amini B. Pulmonary Pneumocystis jirovecii infection | Radiology Reference Article | [online]. Radiopaedia.org. Radiopaedia. [cit. 2024-04-27]. Dostupné z: https://radiopaedia.org/articles/pulmonary-pneumocystis-jirovecii-infection-2?lang=us.

12. Bell DJ. COVID-19 | Radiology Reference Article | [online]. Radiopaedia.org. Radiopaedia. [cit.2024-04-27]. Dostupné z: https://radiopaedia.org/articles/covid-19-4?lang=us.

13. Centers for Disease Control and Prevention. CDC’s influenza SARS-CoV-2 multiplex assay. [online] Centers for Disease Control and Prevention. [cit. 2024-04-27]. Dostupné z: https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html.

14. Oddělení klinické mikrobiologie ÚLM FN Brno. Ceník PCR mikrobiologie výkony 2024. [cit.2024-03-21].

15. MEDILA s.r.o. Ceník | MEDILA [online]. [cit.2024-04-24]. Dostupné z: https://www.medila.cz/cenik.

16. Centers for Disease Control and Prevention. Rapid influenza diagnostic tests. [online], CDC. [cit. 2024-04-27]. Dostupné
z: https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm.

17. EUC. JusChek SARS-CoV-2 a chřipka A/B antigen.test 1ks. [online] EUC Lékárna. [cit. 2024-04-27]. Dostupné z: https://www.euclekarna.cz/zdravotnicke-potreby/testy/testy-covid-19/58729/juschek-sars-cov-2-a-chripka-a/b-antigen.test-1ks.

18. MOBLER. Flowflex 20ks – Sars CoV2 – Chřipka A/B - RSV - Adenovirus Antigen Combo Rapid Test – Acon Biotech, [online]. MOBLER. mobler.cz. [cit.2024-04-27]. Dostupné z: https://www.mobler.cz/flowflex-20ks-sars-cov2-chripka-a-b-rsv-adenovirus-antigen-combo-rapid-test-acon-biotech/.

19. Seki Y, Oda Y, Sugaya N. Very high sensitivity of a rapid influenza diagnostic test in adults and elderly individuals within 48 hours of the onset of illness. PLoS One 2020; 15(5): e0231217.

20. Centers for Disease Control and Prevention. Rapid diagnostic testing for influenza: information for clinical laboratory directors. [online] CDC. [cit.2024-04-27]. Dostupné z: https://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm.

21. Centers for Disease Control and Prevention. Information on rapid molecular assays, RT-PCR, and other molecular assays for diagnosis of influenza virus infection. [online]. CDC. [cit.2024-04-27]. Dostupné z: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm.

22. Test na chřipku A/B cobas Influenza A/B Assay. Diagnostika. [online] [cit. 2024-04-27]. Dostupné z: https://diagnostics.roche.com/cz/cs/products/params/cobas-influenza-a-b-assay.html.

23. Společnost infekčního lékařství ČLS JEP. Praktický návod diagnostiky a léčby chřipky pro nadcházející sezónu. [online] [cit.2024-04-27]. Dostupné z: https://infektologie.cz/zprava19-01.htm.

24. Centers for Disease Control and Prevention. What you should know about flu antiviral drugs. [online] Centers for Disease Control and Prevention. [cit. 2024-04-21]. Dostupné z: https://www.cdc.gov/flu/treatment/whatyoushould.htm.

25. Státní ústav pro kontrolu léčiv. Databáze léků. [online]. SÚKL. [cit. 2024-04-21]. Dostupné z: https://prehledy.sukl.cz/mr.html#/.

26. Státní ústav pro kontrolu léčiv. Tamiflu (0027698 – 75MG CPS DUR 10). SÚKL – Přehled léčiv. [online] SÚKL. [cit. 2024-04-21]. Dostupné z: https://prehledy.sukl.cz/prehled_leciv.html#/.

27. World Health Organization. Guidelines for the clinical management of severe illness from influenza virus infections. [online]. World Health Organization 2022. [cit. 2024-04-24]. Dostupné z: https://iris.who.int/handle/10665/352453.

28. Kuo YC, Lai CC, Wang YH, et al. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi 2021; 54(5): 865–875.

29. Lampejo T. Is combination antiviral therapy for influenza the optimal approach? Lancet Infect Dis 2022; 22(5): 587–588.

30. Česká vakcinologická společnost ČLS JEP. Doporučení České vakcinologické společnosti ČLS JEP k očkování proti chřipce. [online] [cit. 2024-04-24]. Dostupné z: www.vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-3.

31. Nemocniční lékárna FN Brno. Aktuální ceník Nemocniční lékárny FN Brno.

32. Centers for Disease Control and Prevention. How to prevent flu. [online]. Centers for Disease Control and Prevention. [cit. 2024-04-27]. Dostupné z: https://www.cdc.gov/flu/prevent/prevention.htm.

33. Všeobecná zdravotní pojišťovna ČR. Metodický postup k vykazování očkování od 9. 4. 2024. [online]. VZP ČR. [cit. 2024-04-27]. Dostupné z: https://www.vzp.cz/poskytovatele/informace-pro-praxi/ockovani/metodicky-postup-k-vykazovani-ockovani.

34. Populační přehled proočkovanosti proti chřipce. [online]. NZIP.cz. [cit.2024-04-27]. Dostupné z: https://www.nzip.cz/clanek/1698-populacni-prehled-proockovanosti-proti-chripce-se-zamerenim-na-rizikove-skupiny-obyvatel.

35. Česká vakcinologická společnost ČLS JEP. Doporučení České vakcinologické společnosti ČLS JEP pro očkování proti pneumokokovým onemocněním. [online] [cit. 2024-04-24]. Dostupné z: https://www.vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-pro-ockovani-proti-pneumokokovym-onemocnenim.

36. Sdělení č. 118/2024 Sb. Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek proti pneumokokovým infekcí pro očkování pojištěnců nad 65 let věku. Zákony pro lidi [online]. [vid. 2024-05-23]. Dostupné z: https://www.zakonyprolidi.cz/cs/2024-118

Labels

Geriatrics General practitioner for adults Orthopaedic prosthetics

Editorial

Frailty – relationship to selected comorbidities in hospitalized seniors over 28 years

New parameters for assessing glucose metabolism in elderly patients with diabetes mellitus

Benefits and risks of new antidiabetic drugs for the treatment of elderly diabetics

White coat hypertension and masked hypertension

Diabetic foot syndrome – a serious complication of diabetes mellitus even in the elderly

Consiliary palliative team and its benefits for polymorbid geriatric patients

Article was published in

Geriatrics and Gerontology

2024 Issue 2

Popular this week